Olivia's Feed
Dec 19, 2014

Exclusive: Paulson & Co takes stake in Salix on heels of inventory issues – sources

By Olivia Oran, Nadia Damouni and Jessica Toonkel

(Reuters) – Hedge fund Paulson & Co has taken a stake in specialty pharmaceuticals company Salix Pharmaceuticals Ltd (SLXP.O: Quote, Profile, Research, Stock Buzz) as the company recovers from inventory issues and the departure of its chief financial officer, according to people familiar with the matter.

The size of Paulson’s stake was not immediately clear, the people said.

Separately, some top shareholders said they are pushing for Raleigh, North Carolina-based Salix to consider a sale. It is not clear if Paulson is part of that group.

Dec 18, 2014

Paulson & Co takes stake in Salix on heels of inventory issues -sources

Dec 18 (Reuters) – Hedge fund Paulson & Co has taken a stake
in specialty pharmaceuticals company Salix Pharmaceuticals Ltd
as the company recovers from inventory issues and the
departure of its chief financial officer, according to people
familiar with the matter.

The size of Paulson’s stake was not immediately clear, the
people said.

Separately, some top shareholders said they are pushing for
Raleigh, North Carolina-based Salix to consider a sale. It is
not clear if Paulson is part of that group.

Dec 18, 2014

Paulson & Co takes stake in Salix; firm faces inventory issues -sources

By Olivia Oran, Nadia Damouni and Jessica Toonkel

(Reuters) – Hedge fund Paulson & Co has taken a stake in specialty pharmaceuticals company Salix Pharmaceuticals Ltd (SLXP.O: Quote, Profile, Research, Stock Buzz) as the company recovers from inventory issues and the departure of its chief financial officer, according to people familiar with the matter.

The size of Paulson’s stake was not immediately clear, the people said.

Separately, some top shareholders said they are pushing for Raleigh, North Carolina-based Salix to consider a sale. It is not clear if Paulson is part of that group.

Dec 17, 2014

TPG growth fund invests in beauty brand Beautycounter: source

By Olivia Oran

(Reuters) – The growth arm of private equity firm TPG has made an investment in non-toxic beauty company Beautycounter, according to a person familiar with the matter, who said an announcement is expected on Wednesday.

Beautycounter, a seller of skincare and cosmetics, was founded in Santa Monica in 2013 by Gregg Renfrew, the company’s chief executive. The company bans over 1,500 harmful ingredients from its products, including animal fats and oils, formaldehyde and coal tar, which are linked to skin irritation, cancer and hormone disruption.

Dec 11, 2014

Thomas H. Lee Partners in talks to acquire Curo Health-sources

Dec 11 (Reuters) – Private firm Thomas H. Lee Partners LP is
in discussions to acquire U.S. hospice firm Curo Health Services
from private equity firm GTCR LLC, according to people familiar
with the matter, in a deal that could top $700 million,
including debt.

The talks have been in progress for the last few weeks and
there is no certainty a deal will be reached, the people said
this week, asking not to be identified because the negotiations
are private.

Dec 8, 2014

Obamacare helps private equity get its rehab clinic fix

By Olivia Oran

(Reuters) – Investors are pouring money into the operators of U.S. rehab centers as many more Americans get health care coverage for addiction treatment, driving up valuations and triggering a consolidation of businesses in the fragmented sector.

Under President Barack Obama’s healthcare law, new health plans must cover ten core health benefit areas. This includes substance abuse and mental health disorders, opening up services such as alcohol and drug detox or addiction therapy to many Americans who previously couldn’t afford them.

Dec 5, 2014

Exclusive: JH Partners sells stake in jeweler Alex and Ani – sources

By Olivia Oran

(Reuters) – Private equity firm JH Partners has sold its 40 percent stake in jeweler Alex and Ani, according to people familiar with the matter, who added the charm bracelet maker could be worth as much as $1 billion.

San Francisco-based JH Partners, which bought the stake in 2012, sold its holding to British buyout firm Lion Capital LLP, three people confirmed this week.

Dec 5, 2014

JH Partners sells stake in jeweler Alex and Ani -sources

Dec 5 (Reuters) – Private equity firm JH Partners has sold
its 40 percent stake in jeweler Alex and Ani, according to
people familiar with the matter, who added the charm bracelet
maker could be worth as much as $1 billion.

San Francisco-based JH Partners, which bought the stake in
2012, sold its holding to British buyout firm Lion Capital LLP,
three people confirmed this week.

Dec 4, 2014

KKR to invest in Arbor Pharmaceuticals -sources

Dec 4 (Reuters) – KKR & Co LP has agreed to acquire
a significant minority stake in Arbor Pharmaceuticals LLC, in a
deal that values the privately held specialty drugmaker at more
than $1 billion, including debt, people familiar with the matter
said on Thursday.

KKR, a New York-based private equity firm, will own more
than a quarter of Arbor Pharmaceuticals under the terms of the
deal, the people said, asking not to be identified ahead of an
official announcement.

Dec 3, 2014

Exclusive – Johnson & Johnson hires Goldman to explore sale of Splenda: sources

NEW YORK/LONDON (Reuters) – Johnson & Johnson (JNJ.N: Quote, Profile, Research), the U.S.-based healthcare company, has hired Goldman Sachs (GS.N: Quote, Profile, Research) to explore a sale of its artificial sweetener brand Splenda, sources familiar with the matter told Reuters.

The process is at an early stage, with prospective buyers currently signing non-disclosure agreements, one of the sources said, speaking on condition of anonymity because the matter is private.